We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
LHC Group (LHCG) Expands Hospice Presence with New Buyout
Read MoreHide Full Article
LHC Group, Inc. recently inked a deal to acquire Heart of Hospice from EPI Group, LLC, which is a Charleston, SC-based family-owned holding company. The buyout will enable LHC Group to broaden its hospice foothold in five states. Notably, the transaction comprises 16 hospice agencies in Arkansas, Louisiana, Mississippi, Oklahoma and South Carolina.
The acquisition is anticipated to get completed during the third quarter of 2021, subject to customary closing conditions.
It is worth mentioning here that LHC Group operates more than 120 hospice locations throughout the nation.
This transaction is likely to provide a substantial boost to the company’s hospice business line.
Deal Rationale
Heart of Hospice’s mission and vision complement LHC Group’s core values. The combination of these companies will help patients and families through the difficult period related to end-of-life care.
Image Source: Zacks Investment Research
Additionally, the transaction aligns with the company’s strategy of keeping and operating under a family of well-known local brands.
Notably, LHC Group projects annualized revenues of around $92.5 million from this buyout, while also noting that it will not materially impact its 2021 earnings per share. The providers will continue to function under the Heart of Hospice name.
Market Prospects
Per a report by Market Data Forecast, the global hospice market size is anticipated to see a CAGR of 9.1% between 2021 and 2026. Hence, the acquisition comes at an opportune time for the company.
Recent Developments
In May, LHC Group announced its decision to acquire Heart ‘n Home Hospice, which marks its foray into hospice services in the state of Oregon. The buyout also expands LHC Group’s foothold in Idaho.
In the same month, the company agreed to acquire two Casa de la Luz provider locations in Tucson, AZ. The transaction is anticipated to get completed on Jul 1, 2021, subject to certain customary closing conditions. Notably, this buyout is likely to expand LHC Group’s scope of services in the Tuscon market.
Price Performance
Shares of the Zacks Rank #3 (Hold) company have gained 20.8% in a year’s time, compared with the industry’s growth of 11.5%.
HCA Healthcare’s long-term earnings growth rate is expected at 12.3%.
DaVita’s long-term earnings growth rate is estimated at 14.4%.
Illumina’s long-term earnings growth rate is projected at 7%.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Image: Bigstock
LHC Group (LHCG) Expands Hospice Presence with New Buyout
LHC Group, Inc. recently inked a deal to acquire Heart of Hospice from EPI Group, LLC, which is a Charleston, SC-based family-owned holding company. The buyout will enable LHC Group to broaden its hospice foothold in five states. Notably, the transaction comprises 16 hospice agencies in Arkansas, Louisiana, Mississippi, Oklahoma and South Carolina.
The acquisition is anticipated to get completed during the third quarter of 2021, subject to customary closing conditions.
It is worth mentioning here that LHC Group operates more than 120 hospice locations throughout the nation.
This transaction is likely to provide a substantial boost to the company’s hospice business line.
Deal Rationale
Heart of Hospice’s mission and vision complement LHC Group’s core values. The combination of these companies will help patients and families through the difficult period related to end-of-life care.
Image Source: Zacks Investment Research
Additionally, the transaction aligns with the company’s strategy of keeping and operating under a family of well-known local brands.
Notably, LHC Group projects annualized revenues of around $92.5 million from this buyout, while also noting that it will not materially impact its 2021 earnings per share. The providers will continue to function under the Heart of Hospice name.
Market Prospects
Per a report by Market Data Forecast, the global hospice market size is anticipated to see a CAGR of 9.1% between 2021 and 2026. Hence, the acquisition comes at an opportune time for the company.
Recent Developments
In May, LHC Group announced its decision to acquire Heart ‘n Home Hospice, which marks its foray into hospice services in the state of Oregon. The buyout also expands LHC Group’s foothold in Idaho.
In the same month, the company agreed to acquire two Casa de la Luz provider locations in Tucson, AZ. The transaction is anticipated to get completed on Jul 1, 2021, subject to certain customary closing conditions. Notably, this buyout is likely to expand LHC Group’s scope of services in the Tuscon market.
Price Performance
Shares of the Zacks Rank #3 (Hold) company have gained 20.8% in a year’s time, compared with the industry’s growth of 11.5%.
Key Picks
Some better-ranked stocks from the broader medical space are HCA Healthcare, Inc. (HCA - Free Report) , DaVita Inc. (DVA - Free Report) and Illumina, Inc. (ILMN - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
HCA Healthcare’s long-term earnings growth rate is expected at 12.3%.
DaVita’s long-term earnings growth rate is estimated at 14.4%.
Illumina’s long-term earnings growth rate is projected at 7%.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How to Profit from Trillions on Spending for Infrastructure >>